BOZZINI, SARA
 Distribuzione geografica
Continente #
NA - Nord America 2.151
AS - Asia 1.353
EU - Europa 1.253
SA - Sud America 160
AF - Africa 57
Continente sconosciuto - Info sul continente non disponibili 47
OC - Oceania 1
Totale 5.022
Nazione #
US - Stati Uniti d'America 2.062
CN - Cina 634
SG - Singapore 317
IE - Irlanda 270
IT - Italia 231
DE - Germania 143
RU - Federazione Russa 135
HK - Hong Kong 124
FI - Finlandia 112
UA - Ucraina 111
BR - Brasile 107
VN - Vietnam 103
FR - Francia 72
GB - Regno Unito 54
CA - Canada 43
IN - India 39
SE - Svezia 33
BD - Bangladesh 32
ZA - Sudafrica 31
AR - Argentina 20
PL - Polonia 18
BE - Belgio 14
IL - Israele 13
NL - Olanda 13
AT - Austria 12
JP - Giappone 12
MX - Messico 12
TR - Turchia 12
CO - Colombia 9
ES - Italia 8
IQ - Iraq 8
MY - Malesia 8
PK - Pakistan 8
GT - Guatemala 7
MA - Marocco 7
VE - Venezuela 6
CL - Cile 5
CR - Costa Rica 5
CW - ???statistics.table.value.countryCode.CW??? 5
CZ - Repubblica Ceca 5
GP - Guadalupe 5
KR - Corea 5
SA - Arabia Saudita 5
UZ - Uzbekistan 5
AL - Albania 4
EC - Ecuador 4
HN - Honduras 4
ID - Indonesia 4
JM - Giamaica 4
OM - Oman 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
BO - Bolivia 3
DZ - Algeria 3
KZ - Kazakistan 3
NG - Nigeria 3
PE - Perù 3
PR - Porto Rico 3
RO - Romania 3
TN - Tunisia 3
BH - Bahrain 2
CI - Costa d'Avorio 2
DK - Danimarca 2
HU - Ungheria 2
KE - Kenya 2
LV - Lettonia 2
PS - Palestinian Territory 2
PY - Paraguay 2
RS - Serbia 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
AU - Australia 1
BN - Brunei Darussalam 1
BS - Bahamas 1
BY - Bielorussia 1
BZ - Belize 1
CD - Congo 1
CH - Svizzera 1
DJ - Gibuti 1
EG - Egitto 1
EU - Europa 1
GY - Guiana 1
IS - Islanda 1
JO - Giordania 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
LY - Libia 1
MD - Moldavia 1
MR - Mauritania 1
MT - Malta 1
MU - Mauritius 1
NI - Nicaragua 1
PA - Panama 1
PH - Filippine 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
Totale 4.981
Città #
Dublin 270
Chandler 224
San Jose 220
Singapore 179
Ashburn 177
Jacksonville 145
Beijing 138
Hong Kong 121
Nanjing 105
Dallas 100
Council Bluffs 68
Boardman 66
Los Angeles 59
Ann Arbor 58
Pavia 56
Princeton 41
Nanchang 39
Helsinki 38
Lauterbourg 38
Munich 38
Lawrence 37
Shenyang 36
Medford 35
Wilmington 34
Milan 32
Changsha 30
Johannesburg 30
New York 30
Hebei 28
Ho Chi Minh City 28
Hanoi 27
Jiaxing 27
Moscow 27
Shanghai 27
Hangzhou 24
Seattle 24
Tianjin 23
Orem 21
Montreal 19
São Paulo 18
Warsaw 17
Buffalo 15
Santa Clara 15
Brussels 14
Redondo Beach 14
Turku 13
Atlanta 12
Tokyo 12
Brooklyn 11
London 11
Piscataway 11
Woodbridge 11
Chennai 10
Dearborn 10
The Dalles 10
Amsterdam 9
Toronto 9
Vienna 9
Denver 8
Falkenstein 8
Istanbul 8
Zhengzhou 8
Boston 7
Kunming 7
New Delhi 7
Norwalk 7
Stockholm 7
Chicago 6
Frankfurt am Main 6
Guatemala City 6
Manchester 6
Meda 6
Mexico City 6
Phoenix 6
Poplar 6
Rio de Janeiro 6
Rome 6
Verona 6
Bareggio 5
Brescia 5
Columbus 5
Haiphong 5
North Bergen 5
Willemstad 5
Ankara 4
Biên Hòa 4
Charlotte 4
Dhaka 4
Elk Grove Village 4
Florence 4
Kuala Lumpur 4
Milwaukee 4
Modena 4
Muscat 4
Philadelphia 4
Quito 4
Raleigh 4
San Francisco 4
San José 4
Secaucus 4
Totale 3.177
Nome #
Age of Onset of Myocardial Infarction: Is Promoter Polymorphism of the RAGE Gene Implicated? 188
Studio di genere: possibile ruolo del polimorfismo Val66Met del BDNF nella malattia coronarica e nella depressione. 185
Soluble RAGE Plasma Levels in Patients with Coronary Artery Disease and Peripheral Artery Disease 157
Atrial fibrillation recurrence and expression levels of apelin-regulating miRNAs 151
Cloning and expression of two different genes from Streptococcus dysgalactidae encoding fibronectin receptors 149
-374T/A and -429 T/C polymorphisms of the RAGE gene in Myocardial Infarction. 148
Galectin-3 plasma levels andcoronary artery disease: a new possible biomarker of acute coronary syndrome. 148
Infarto miocardico ed età di insorgenza: è implicato il polimorfismo -374T/A del gene RAGE nello studio di genere? 145
Anti-Ro52 antibodies positivity in antisynthetase syndrome: a single centre cohort study 145
Association between two polymorphisms in the HLA-G gene and angiographic coronaryartery disease 143
Studio del polimorfismo 14 bp inserzione/delezione nel gene HLA-G e insorgenza della CAD (Coronary Artery Disease) 143
Hyaluronic acid-decorated liposomes as innovative targeted delivery system for lung fibrotic cells 140
Broncho-alveolar inflammation in COVID-19 patients: a correlation with clinical outcome 140
Studio dei polimorfismi nel gene del recettore dell’apelina in pazienti con e senza ipertensione arteriosa 134
Cardiovascular characteristics of Chronic Fatigue Syndrome 131
Coronary artery disease and depression: possible role of brain-derived neurotrophic factor and serotonin transporter gene polymorphisms 126
APJ polymorphisms in coronary artery disease patients with and without hypertension. 125
Neutrophil Extracellular Traps Induce the Epithelial-Mesenchymal Transition: Implications in Post-COVID-19 Fibrosis 123
Correlazione tra livelli plasmatici di galactina e aterosclerosi coronarica: nuovo marcatore di instabilità clinica? 122
Functional polymorphisms of the receptor for the advanced glycation end product promoter gene in inflammatory bowel disease: a case–control study 121
Age of onset of myocardial infarction: is promoter polymorphism of the RAGE gene implicated? 120
Cardiovascular risk factors and Sympatho-Vagal balance: Importance of time-domain heart rate variability 120
CD14 polymorphisms and ACS (Acute Coronary Syndromes) 118
Relationship between sRAGE and eotaxin-3 with CRP in hypertensive patients at high cardiovascular risk. 115
Autoantibodies, polymorphisms in the serotonin pathway, and human leukocyte antigen class II alleles in chronic fatigue syndrome: are they associated with age at onset and specific symptoms? 115
miRNAs Potentially Involved in Post Lung Transplant-Obliterative Bronchiolitis: The Role of miR-21-5p 109
Excess of activating killer cell immunoglobulin-like receptors and lack of HLA-Bw4 ligands: a two-edged weapon in chronic fatigue syndrome 108
Microalbuminuria and sRAGE in High-Risk Hypertensive Patients Treated with Nifedipine/Telmisartan Combination Treatment: A Substudy of TALENT 107
Time-Domain Heart Rate Variability in Coronary Artery Disease Patients Affected by Thyroid Dysfunction 105
Plasma Levels of Soluble Receptor for Advanced Glycation End Products and Coronary Atherosclerosis: Possible Correlation with Clinical Presentation 104
RAGE gene polymorphism in heart failure patients with and without angiographic evidence of significant coronary atherosclerosis. 101
Loading Imatinib inside targeted nanoparticles to prevent Bronchiolitis Obliterans Syndrome 100
Possible involvment of HLA-G polymorphism in CAD (Coronary Artery Disease) development: association with risk factors 98
Primary headache and silent myocardial ischemia in patients with coronary artery disease. 98
Polimorfismo -374 T/A nel promotore del gene RAGE e longevità: confronto tra popolazioni con differente età 91
Liposomes Loaded with Everolimus and Coated with Hyaluronic Acid: A Promising Approach for Lung Fibrosis 88
Livelli plasmatici di apelina in pazienti con fibrillazione atriale 87
Investigating the Link between Alpha-1 Antitrypsin and Human Neutrophil Elastase in Bronchoalveolar Lavage Fluid of COVID-19 Patients 84
Polimorfismi del gene CR1: studio di genere nella malattia coronarica. 82
Toll-like receptor 4 polymorphisms in disease with inflammatory component 77
sRAGE and early signs of cardiac target organ damage in mild hypertensives 67
Molecular study of receptor for advanced glycation endproduct gene promoter and identification of specific HLA haplotypes possibly involved in chronic fatigue syndrome 64
Totale 5.022
Categoria #
all - tutte 20.192
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.192


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022161 0 0 0 0 2 9 3 10 8 6 26 97
2022/2023696 79 62 13 57 63 56 0 36 296 9 16 9
2023/2024250 31 44 5 15 15 38 8 31 4 20 22 17
2024/2025712 26 46 31 24 14 47 30 29 170 31 86 178
2025/20261.656 121 93 181 176 225 78 303 104 170 109 48 48
2026/2027408 21 66 93 133 95 0 0 0 0 0 0 0
Totale 5.022